PPIB and fibrosis: Comparison of SfA and SfA-mc, which similarly inhibit and induce PPIB secretion, indicates that targeting PPIB may be separable from the immunosuppressive effects of SfA, and further structure-activity relationship studies may yield optimized molecules for treatment of fibrosis.